ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

The Value of Circulating Biomarkers in Bicuspid Aortic Valve-Associated Aortopathy

Wednesday, June 13, 2018

Submitted by

Claire Vernon

Source

Source Name: The Thoracic and Cardiovascular Surgeon

Source URL: https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0036-1583525

Author(s)

Shiho Naito, Mathias Hillebrand, Alexander Martin Justus Bernhardt, Annika Jagodzinski, Lenard Conradi, Christian Detter, Karsten Sydow, Hermann Reichenspurner, Yskert von Kodolitsch, Evaldas Girdauskas

Size-based parameters have both value and limitations in predicting the risk of aortopathy in patients with bicuspid aortic valves. Given the limitations of these morphological predictive tools, Naito and colleagues review the potential of biomarkers to assess aortic disease in these patients. The authors discuss evidence for markers that are more routinely available for testing, such as MMPs, TIMPs, and alpha 1-antitrypsin, as well as those markers that are primarily experimental.